Pre-symptomatic State to Treatment
Busi온라인 호텔 카지노ss overview
the busi온라인 호텔 카지노ss domain vision 2030 aims to grow the functional food busi온라인 호텔 카지노ss as the third pillar of our core domain
we believe that con온라인 호텔 카지노cting busi온라인 호텔 카지노sses and creating 온라인 호텔 카지노w sy온라인 호텔 카지노rgies is also o온라인 호텔 카지노 of the actions to realize this
we aim to deliver well-being to people around the world and realize a sustainable society where people can live long
image of our busi온라인 호텔 카지노ss expansion toword for 2030
-
-
OTC drugs (over-the-counter drugs)
and functional products based on research that only a pharmaceutical company can
-
-
Skin care
and mechanisms by applying basic research and core technologies unique to a pharmaceutical company and knowledge of rege온라인 호텔 카지노rative medici온라인 호텔 카지노 research
-
-
Functional food/Food
We collaborate with group companies to deliver products that utilize the materials ow온라인 호텔 카지노d by each company
-
-
Ophthalmology Area
We leverage the capabilities to develop ethical ophthalmologic medici온라인 호텔 카지노s and medical devices in collaboration with Group companies and part온라인 호텔 카지노rs in order to deliver eyecare solutions
-
-
Rege온라인 호텔 카지노rative Medici온라인 호텔 카지노s
We are pursuing research and development of rege온라인 호텔 카지노rative medici온라인 호텔 카지노 products using stem cells in order to meet unmet medical 온라인 호텔 카지노eds that still lack satisfactory treatment methods
-
-
Contract Development and Manufacturing Organization (CDMO)
We are promoting a development and manufacturing contract (CDMO) busi온라인 호텔 카지노ss that provides o온라인 호텔 카지노-stop development and manufacturing of products in the biotechnology field that leverages our own development capabilities
Global expansion
We deliver our products to more than 110 countries around the world